We are live on ! Find out more
RPTX

Repare Therapeutics

Delisted

RPTX was delisted on the 27th of January, 2026.

67 hedge funds and large institutions have $689M invested in Repare Therapeutics in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 16

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

5.69% more ownership

Funds ownership: 72.63%78.31% (+5.7%)

2% more funds holding

Funds holding: 6667 (+1)

3% less capital invested

Capital invested by funds: $708M → $689M (-$18.2M)

7% less call options, than puts

Call options by funds: $207K | Put options by funds: $223K

Holders
67
Holders Change
+1
Holders Change %
+1.52%
% of All Funds
1.03%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.08%
New
11
Increased
29
Reduced
16
Closed
10
Calls
$207K
Puts
$223K
Net Calls
-$16K
Net Calls Change
-$1.32M
Name Holding Trade Value Shares
Change
Change in
Stake
State Street
26
State Street
Massachusetts
$1.32M +$843K +35,805 +135%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$1.08M +$287K +12,195 +31%
EC
28
EcoR1 Capital
California
$1.05M
HS
29
HighVista Strategies
Massachusetts
$917K +$174K +7,393 +20%
Swiss National Bank
30
Swiss National Bank
Switzerland
$778K +$379K +16,100 +77%
Morgan Stanley
31
Morgan Stanley
New York
$736K -$1.24M -52,462 -60%
SG Americas Securities
32
SG Americas Securities
New York
$725K +$179K +7,587 +28%
Bank of America
33
Bank of America
North Carolina
$672K +$199K +8,459 +36%
Goldman Sachs
34
Goldman Sachs
New York
$656K -$213K -9,061 -23%
CSS
35
Cubist Systematic Strategies
Connecticut
$631K +$703K +29,843 +29,843%
TCM
36
Tekla Capital Management
Massachusetts
$615K +$687K +29,150 New
Point72 Asset Management
37
Point72 Asset Management
Connecticut
$601K -$735K -31,198 -52%
JP Morgan Chase
38
JP Morgan Chase
New York
$502K -$112K -4,768 -17%
Geode Capital Management
39
Geode Capital Management
Massachusetts
$451K
Northern Trust
40
Northern Trust
Illinois
$442K +$122K +5,161 +33%
TI
41
Trexquant Investment
Connecticut
$429K +$137K +5,817 +40%
Citigroup
42
Citigroup
New York
$426K -$121K -5,118 -20%
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$400K +$447K +18,979 New
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$293K +$149K +6,339 +84%
DekaBank Deutsche Girozentrale
45
DekaBank Deutsche Girozentrale
Germany
$275K +$9.42K +400 +3%
HP
46
Harbourvest Partners
Massachusetts
$259K
Blackstone Inc
47
Blackstone Inc
New York
$250K
Mitsubishi UFJ Asset Management
48
Mitsubishi UFJ Asset Management
Japan
$231K +$37.7K +1,599 +18%
ECM
49
ExodusPoint Capital Management
New York
$229K +$255K +10,846 New
VEA
50
Virtus ETF Advisers
New York
$176K +$44.1K +1,873 +29%

RPTX Hedge Fund Activity: Q4 2021 in Review

67 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q4 2021, worth a combined $689M — down 2.6% from $708M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new RPTX positions and 10 closed out — a net gain of 1 holder — while 29 added to existing stakes and 16 trimmed.

The largest buyer was Logos Global Management, adding an estimated $39.6M. The largest seller was Sectoral Asset Management, cutting an estimated $7.3M.

  • 67 institutional investors held Repare Therapeutics (RPTX) as of Q4 2021, up from 66 in Q3 2021.
  • Funds reported $689M of Repare Therapeutics stock for Q4 2021, down 2.6% quarter-over-quarter.
  • 11 funds opened new Repare Therapeutics positions in Q4 2021 and 10 closed out, a net change of +1 holder.
  • The largest Repare Therapeutics buyer in Q4 2021 was Logos Global Management, an estimated $39.6M added.
  • The largest Repare Therapeutics seller in Q4 2021 was Sectoral Asset Management, an estimated $7.3M sold.

Based on aggregated 13F filings for Q4 2021.